Shares of Johnson Matthey PLC (LON:JMAT) have been given a consensus rating of “Buy” by the seven research firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating and six have issued a buy rating on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is GBX 3,860 ($50.44).
A number of brokerages recently commented on JMAT. Deutsche Bank reaffirmed a “buy” rating on shares of Johnson Matthey in a research note on Thursday, July 18th. HSBC lifted their price objective on Johnson Matthey from GBX 3,650 ($47.69) to GBX 3,750 ($49.00) and gave the stock a “buy” rating in a research note on Wednesday, June 5th. UBS Group reissued a “sell” rating on shares of Johnson Matthey in a research note on Thursday, July 18th. Berenberg Bank boosted their target price on Johnson Matthey from GBX 3,600 ($47.04) to GBX 3,750 ($49.00) and gave the company a “buy” rating in a research note on Monday, June 3rd. Finally, Credit Suisse Group reissued an “outperform” rating on shares of Johnson Matthey in a research note on Friday, May 31st.
Shares of LON JMAT traded up GBX 23 ($0.30) during midday trading on Tuesday, hitting GBX 2,793 ($36.50). The stock had a trading volume of 952,276 shares, compared to its average volume of 691,012. The company’s 50-day simple moving average is GBX 3,157.10 and its 200 day simple moving average is GBX 3,176.88. The firm has a market cap of $5.41 billion and a P/E ratio of 13.01. Johnson Matthey has a fifty-two week low of GBX 2,574 ($33.63) and a fifty-two week high of GBX 3,692 ($48.24). The company has a debt-to-equity ratio of 50.40, a current ratio of 1.64 and a quick ratio of 0.95.
In other Johnson Matthey news, insider Robert MacLeod bought 12 shares of the firm’s stock in a transaction on Wednesday, July 17th. The stock was purchased at an average cost of GBX 3,225 ($42.14) per share, with a total value of £387 ($505.68).
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Article: Average Daily Trade Volume – ADTV
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.